These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 11924920)

  • 61. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus.
    Hahn BH
    J Rheumatol Suppl; 1997 May; 48():89-93. PubMed ID: 9150126
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of severe autoimmune disease by stem-cell transplantation.
    Sykes M; Nikolic B
    Nature; 2005 Jun; 435(7042):620-7. PubMed ID: 15931215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.
    Szodoray P; Varoczy L; Papp G; Barath S; Nakken B; Szegedi G; Zeher M
    Scand J Rheumatol; 2012 Mar; 41(2):110-5. PubMed ID: 21936606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Refractory juvenile idiopathic arthritis: using autologous stem cell transplantation as a treatment strategy.
    Wulffraat NM; de Kleer IM; Prakken B
    Expert Rev Mol Med; 2006 Nov; 8(26):1-11. PubMed ID: 17107631
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hematopoietic stem cell transplantation in multiple sclerosis.
    Rogojan C; Frederiksen JL
    Acta Neurol Scand; 2009 Dec; 120(6):371-82. PubMed ID: 19785643
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity.
    De Kleer IM; Brinkman DM; Ferster A; Abinun M; Quartier P; Van Der Net J; Ten Cate R; Wedderburn LR; Horneff G; Oppermann J; Zintl F; Foster HE; Prieur AM; Fasth A; Van Rossum MA; Kuis W; Wulffraat NM
    Ann Rheum Dis; 2004 Oct; 63(10):1318-26. PubMed ID: 15361393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stem cell transplantation in multiple sclerosis: safety and ethics.
    Silani V; Cova L
    J Neurol Sci; 2008 Feb; 265(1-2):116-21. PubMed ID: 17619025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activity survey and historical perspective of autologous stem cell transplantation in Europe.
    Gratwohl A
    Semin Hematol; 2007 Oct; 44(4):220-6. PubMed ID: 17961720
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellular therapy of systemic lupus erythematosus.
    Tyndall A
    Lupus; 2009 Apr; 18(5):387-93. PubMed ID: 19318389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peripheral blood stem cell transplantation for rheumatoid arthritis--Australian experience.
    Moore J; Milliken S; David ; Biggs J; Brooks P
    J Rheumatol Suppl; 2001 Oct; 64():8-12. PubMed ID: 11642509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity.
    Alaez C; Loyola M; Murguía A; Flores H; Rodríguez A; Ovilla R; Ignacio G; Amador R; Salinas V; Perez F; Rodríguez D; Morales Z; Llinguin G; Vazquez A; Altamirano A; Gorodezky C
    Autoimmun Rev; 2006 Mar; 5(3):167-79. PubMed ID: 16483916
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases].
    van den Hoogen FH; Schattenberg AV; Breedveld FC; Fibbe WE; van de Putte LB
    Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2061-5. PubMed ID: 9550764
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.
    Sullivan KM; Muraro P; Tyndall A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S48-56. PubMed ID: 19895895
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
    Fassas A; Kimiskidis VK
    J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.
    Rosen O; Thiel A; Massenkeil G; Hiepe F; Häupl T; Radtke H; Burmester GR; Gromnica-Ihle E; Radbruch A; Arnold R
    Arthritis Res; 2000; 2(4):327-36. PubMed ID: 11056673
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stem cell transplantation for autoimmune disorders. Multiple sclerosis.
    Fassas A; Nash R
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):247-62. PubMed ID: 15302338
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases.
    van Bekkum DW
    J Leukoc Biol; 2002 Oct; 72(4):609-20. PubMed ID: 12377928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.